Detalles de la búsqueda
1.
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Cancer;
128(8): 1595-1604, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157306
2.
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.
Blood;
127(9): 1128-37, 2016 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26675347
3.
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.
Blood;
138(9): 811-814, 2021 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189565
4.
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Br J Haematol;
169(4): 506-19, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25712263
5.
Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Mol Cancer;
13: 159, 2014 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24972933
6.
The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma.
Br J Haematol;
162(5): 657-69, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23826755
7.
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models.
Anticancer Drugs;
24(10): 1030-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23995855
8.
AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.
Leuk Lymphoma;
64(6): 1175-1185, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37074033
9.
Early changes in soluble intracellular adhesion molecule-1 as prognostic biomarkers to immune checkpoint inhibitor.
Clin Transl Sci;
16(8): 1396-1407, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317057
10.
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Target Oncol;
18(5): 685-695, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632592
11.
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL.
Blood Adv;
7(7): 1146-1155, 2023 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375132
12.
Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma.
Br J Haematol;
156(4): 490-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22150234
13.
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells.
Blood;
116(25): 5605-14, 2010 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20930068
14.
Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status.
Front Oncol;
12: 933446, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992795
15.
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.
Br J Haematol;
153(5): 599-611, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21492126
16.
Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell Lymphoma.
EJHaem;
1(1): 122-132, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073261
17.
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab.
J Control Release;
328: 160-170, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860930
18.
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma.
Cancer Metab;
8: 10, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32647571
19.
The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance.
Aging (Albany NY);
13(1): 181-193, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288735
20.
Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
Prostate;
69(12): 1312-24, 2009 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19444856